These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 32167792)

  • 1. Effects of Fish Oil Monotherapy on Depression and Prefrontal Neurochemistry in Adolescents at High Risk for Bipolar I Disorder: A 12-Week Placebo-Controlled Proton Magnetic Resonance Spectroscopy Trial.
    McNamara RK; Strawn JR; Tallman MJ; Welge JA; Patino LR; Blom TJ; DelBello MP
    J Child Adolesc Psychopharmacol; 2020 Jun; 30(5):293-305. PubMed ID: 32167792
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of fish oil supplementation on prefrontal metabolite concentrations in adolescents with major depressive disorder: a preliminary 1H MRS study.
    McNamara RK; Jandacek R; Rider T; Tso P; Chu WJ; Weber WA; Welge JA; Strawn JR; Adler CM; DelBello MP
    Nutr Neurosci; 2016 May; 19(4):145-55. PubMed ID: 24915543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil supplementation alters emotion-generated corticolimbic functional connectivity in depressed adolescents at high-risk for bipolar I disorder: A 12-week placebo-controlled fMRI trial.
    McNamara RK; Li W; Lei D; Tallman MJ; Welge JA; Strawn JR; Patino LR; DelBello MP
    Bipolar Disord; 2022 Mar; 24(2):161-170. PubMed ID: 34214231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP; Chang K; Welge JA; Adler CM; Rana M; Howe M; Bryan H; Vogel D; Sampang S; Delgado SV; Sorter M; Strakowski SM
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder.
    Weihs KL; Murphy W; Abbas R; Chiles D; England RD; Ramaker S; Wajsbrot DB
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):36-46. PubMed ID: 29189044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase 3, Double-Blind, Randomized, Placebo-Controlled Study of Vilazodone in Adolescents with Major Depressive Disorder.
    Durgam S; Chen C; Migliore R; Prakash C; Edwards J; Findling RL
    Paediatr Drugs; 2018 Aug; 20(4):353-363. PubMed ID: 29633166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents.
    DelBello MP; Hochadel TJ; Portland KB; Azzaro AJ; Katic A; Khan A; Emslie G
    J Child Adolesc Psychopharmacol; 2014 Aug; 24(6):311-7. PubMed ID: 24955812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder.
    Gracious BL; Chirieac MC; Costescu S; Finucane TL; Youngstrom EA; Hibbeln JR
    Bipolar Disord; 2010 Mar; 12(2):142-54. PubMed ID: 20402707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
    Park Y; Park YS; Kim SH; Oh DH; Park YC
    Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features:
    Singh MK; Pikalov A; Siu C; Tocco M; Loebel A
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):590-598. PubMed ID: 32392455
    [No Abstract]   [Full Text] [Related]  

  • 11. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder.
    DelBello MP; Adler CM; Whitsel RM; Stanford KE; Strakowski SM
    J Clin Psychiatry; 2007 May; 68(5):789-95. PubMed ID: 17503991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
    Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
    Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurometabolite effects of response to quetiapine and placebo in adolescents with bipolar depression.
    Chang K; Delbello M; Chu WJ; Garrett A; Kelley R; Mills N; Howe M; Bryan H; Adler C; Eliassen J; Spielman D; Strakowski SM
    J Child Adolesc Psychopharmacol; 2012 Aug; 22(4):261-8. PubMed ID: 22849427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder.
    Atkinson S; Lubaczewski S; Ramaker S; England RD; Wajsbrot DB; Abbas R; Findling RL
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):55-65. PubMed ID: 29185786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escitalopram in the treatment of adolescent depression: a randomized, double-blind, placebo-controlled extension trial.
    Findling RL; Robb A; Bose A
    J Child Adolesc Psychopharmacol; 2013 Sep; 23(7):468-80. PubMed ID: 24041408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Addition of Fish Oil to Cognitive Behavioral Case Management for Youth Depression: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial.
    Amminger GP; Rice S; Davey CG; Quinn AL; Hermens DF; Zmicerevska N; Nichles A; Hickie I; Incerti L; Weller A; Joseph S; Hilton Z; Pugh C; Rayner M; Reid N; Ratheesh A; Yung AR; Yuen HP; Mackinnon A; Hetrick S; Parker A; Street R; Berger M; Berk M; McGorry PD; Lin A
    Biol Psychiatry; 2024 Mar; 95(5):426-433. PubMed ID: 37355004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.
    Youngstrom E; Zhao J; Mankoski R; Forbes RA; Marcus RM; Carson W; McQuade R; Findling RL
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):72-9. PubMed ID: 23480324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial.
    Keck PE; Versiani M; Potkin S; West SA; Giller E; Ice K;
    Am J Psychiatry; 2003 Apr; 160(4):741-8. PubMed ID: 12668364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Randomized Controlled Trial of Individual Family Psychoeducational Psychotherapy and Omega-3 Fatty Acids in Youth with Subsyndromal Bipolar Disorder.
    Fristad MA; Young AS; Vesco AT; Nader ES; Healy KZ; Gardner W; Wolfson HL; Arnold LE
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):764-74. PubMed ID: 26682997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study.
    DelBello MP; Goldman R; Phillips D; Deng L; Cucchiaro J; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2017 Dec; 56(12):1015-1025. PubMed ID: 29173735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.